FDA NDC Directory · JSON-LD · Markdown

Griseofulvin

NDC 0781-5514 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerSandoz Inc
Marketing categoryAbbreviated NDA (generic) · App ANDA091592
Dosage form / routeTABLET · ORAL
Active ingredientsGRISEOFULVIN (250 mg/1)
Marketing started20130807
Package count2

External sources

Source: openFDA. Public-domain (CC0).